Funding Rounds
Ascend Gene & Cell Therapies

Ascend Gene & Cell Therapies Series A (2023, $65M)

Ascend Gene & Cell Therapies

Gene and cell therapy manufacturing.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $65.90M

Raised Date: 2023-09-01